Paper29643229
T cell-induced CSF1 promotes melanoma resistance to PD1 blockade.
Neubert NJ and 20 others. Sci Transl Med, 2018. Cited by 263 papers, by iCite.
Cite this record
ConductScience Library. T cell-induced CSF1 promotes melanoma resistance to PD1 blockade. Papers, record 29643229. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/29643229
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics15
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Macrophage Colony-Stimulating Factor | Major topic |
| Melanoma | Major topic |
| Animals | |
| Antigens, CD | |
| Antigens, Differentiation, Myelomonocytic | |
| CD8-Positive T-Lymphocytes | |
| Cell Differentiation | |
| Cell Line, Tumor | |
| Humans | |
| Macrophages | |
| Mice | |
| Proto-Oncogene Proteins B-raf | |
| Receptors, Cell Surface | |
| Signal Transduction | |
| CD163 Antigen |
Source PubMed
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| T32 AR007016 | NIAMS NIH HHS | United States | T32AR007016 | PubMed and NIH |
Source NIH RePORTER
References105
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 9348298 | Phenotypic and functional separation of memory and effector human CD8+ T cells. | J Exp Med | 1997 | https://conductscience.org/library/papers/9348298 | PubMed |
| 2 | 19279573 | Microenvironmental regulation of metastasis. | Nat Rev Cancer | 2009 | https://conductscience.org/library/papers/19279573 | PubMed |
| 3 | 29436396 | Rapid activation of tumor-associated macrophages boosts preexisting tumor immunity. | J Exp Med | 2018 | https://conductscience.org/library/papers/29436396 | PubMed |
| 4 | 11104796 | Cross-priming of naive CD8 T cells against melanoma antigens using dendritic cells loaded with killed allogeneic melanoma cells. | J Exp Med | 2000 | https://conductscience.org/library/papers/11104796 | PubMed |
| 5 | 21705455 | The two faces of interferon-γ in cancer. | Clin Cancer Res | 2011 | https://conductscience.org/library/papers/21705455 | PubMed |
| 6 | 23243596 | Trial watch: Prognostic and predictive value of the immune infiltrate in cancer. | Oncoimmunology | 2012 | https://conductscience.org/library/papers/23243596 | PubMed |
| 7 | 23284651 | Prognostic significance of tumor-associated macrophages in solid tumor: a meta-analysis of the literature. | PLoS One | 2012 | https://conductscience.org/library/papers/23284651 | PubMed |
| 8 | 28292435 | Obstacles Posed by the Tumor Microenvironment to T cell Activity: A Case for Synergistic Therapies. | Cancer Cell | 2017 | https://conductscience.org/library/papers/28292435 | PubMed |
| 9 | 17063185 | Interferons, immunity and cancer immunoediting. | Nat Rev Immunol | 2006 | https://conductscience.org/library/papers/17063185 | PubMed |
| 10 | 20856220 | Macrophage plasticity and interaction with lymphocyte subsets: cancer as a paradigm. | Nat Immunol | 2010 | https://conductscience.org/library/papers/20856220 | PubMed |
| 11 | 28104684 | Broad and Conserved Immune Regulation by Genetically Heterogeneous Melanoma Cells. | Cancer Res | 2017 | https://conductscience.org/library/papers/28104684 | PubMed |
| 12 | 25858804 | Immune checkpoint blockade: a common denominator approach to cancer therapy. | Cancer Cell | 2015 | https://conductscience.org/library/papers/25858804 | PubMed |
| 13 | 26051995 | CSF-1/CSF-1R targeting agents in clinical development for cancer therapy. | Curr Opin Pharmacol | 2015 | https://conductscience.org/library/papers/26051995 | PubMed |
| 14 | 18319339 | Unmodified self antigen triggers human CD8 T cells with stronger tumor reactivity than altered antigen. | Proc Natl Acad Sci U S A | 2008 | https://conductscience.org/library/papers/18319339 | PubMed |
| 15 | 19528371 | Macrophage markers in serum and tumor have prognostic impact in American Joint Committee on Cancer stage I/II melanoma. | J Clin Oncol | 2009 | https://conductscience.org/library/papers/19528371 | PubMed |
| 16 | 27192570 | Targeting T Cell Co-receptors for Cancer Therapy. | Immunity | 2016 | https://conductscience.org/library/papers/27192570 | PubMed |
| 17 | 27411586 | The Multifaceted Role of Perivascular Macrophages in Tumors. | Cancer Cell | 2016 | https://conductscience.org/library/papers/27411586 | PubMed |
| 18 | 16034097 | Blockade of B7-H1 on macrophages suppresses CD4+ T cell proliferation by augmenting IFN-gamma-induced nitric oxide production. | J Immunol | 2005 | https://conductscience.org/library/papers/16034097 | PubMed |
| 19 | 24890514 | CSF-1 receptor signaling in myeloid cells. | Cold Spring Harb Perspect Biol | 2014 | https://conductscience.org/library/papers/24890514 | PubMed |
| 20 | 20682855 | An antibody against the colony-stimulating factor 1 receptor depletes the resident subset of monocytes and tissue- and tumor-associated macrophages but does not inhibit inflammation. | Blood | 2010 | https://conductscience.org/library/papers/20682855 | PubMed |
Cited by201
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 263 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42911425 | The pivotal role of macrophages in tumorigenesis and pioneering cancer immunotherapy across pre-clinical and clinical frontiers. | J Cancer Res Clin Oncol | 2026 | https://conductscience.org/library/papers/42911425 | PubMed |
| 42907443 | p38α orchestrates BRAFV600E-melanoma progression and immunotherapy response via tumor fitness and immune microenvironment modulation. | Nat Commun | 2026 | https://conductscience.org/library/papers/42907443 | PubMed |
| 42888442 | Targeting myeloid cell plasticity and metabolic reprogramming to alleviate T cell dysfunction and exhaustion-associated states and enhance immune checkpoint blockade therapy. | Biomark Res | 2026 | https://conductscience.org/library/papers/42888442 | PubMed |
| 42400242 | Comparison of Human Melanoma Single Cell Profiles to Evolutionary Medicine Model Xiphophorus Provides Insights in Disease Control. | Pigment Cell Melanoma Res | 2026 | https://conductscience.org/library/papers/42400242 | PubMed |
| 42370186 | TAM-targeted nanomedicine in cancer: biological basis, therapeutic strategies, and translational perspectives. | Theranostics | 2026 | https://conductscience.org/library/papers/42370186 | PubMed |
| 42177174 | Explainable machine learning identifies features and thresholds predictive of immunotherapy response. | Sci Rep | 2026 | https://conductscience.org/library/papers/42177174 | PubMed |
| 42075611 | Uncovering the Intricate and Heterogeneous Cellular Microenvironment of Cutaneous Melanoma. | Medicina (Kaunas) | 2026 | https://conductscience.org/library/papers/42075611 | PubMed |
| 42001468 | Causal modeling reveals cell-cell communication dynamics in the tumor microenvironment during anti-PD-1 therapy in breast cancer patients. | Brief Bioinform | 2026 | https://conductscience.org/library/papers/42001468 | PubMed |
| 41851817 | The double-edged sword role of tumor-associated macrophages: preventing or causing resistance to immunotherapy. | J Exp Clin Cancer Res | 2026 | https://conductscience.org/library/papers/41851817 | PubMed |
| 41809255 | Macrophage-centered therapy strategies: A promising weapon in cancer immunotherapy. | Asian J Pharm Sci | 2025 | https://conductscience.org/library/papers/41809255 | PubMed |
| 41639044 | Colorectal cancer-derived osteopontin rewires macrophages into a pro-metastatic M2 state via the PI3K/AKT/CSF1-CSF1R axis. | Cell Death Discov | 2026 | https://conductscience.org/library/papers/41639044 | PubMed |
| 41320225 | Single-cell multiomics reveals macrophage-derived IL-23 and CXCL9/10 drive pathogenic IFNG+IL17+ T cells in immunotherapy-related colitis. | J Immunother Cancer | 2025 | https://conductscience.org/library/papers/41320225 | PubMed |
| 41281945 | Targeting tumor-draining lymph node to overcome resistance to cancer immunotherapy: an update. | Cancer Drug Resist | 2025 | https://conductscience.org/library/papers/41281945 | PubMed |
| 41202502 | Retreatment, rechallenge, and escalation with subsequent immune checkpoint inhibitor therapies across cancers after initial failure. | ESMO Open | 2025 | https://conductscience.org/library/papers/41202502 | PubMed |
| 41185627 | Uncovering Cellular Interactome Drivers of Immune Checkpoint Inhibitor Response in Advanced Melanoma Patients. | Cell Mol Bioeng | 2025 | https://conductscience.org/library/papers/41185627 | PubMed |
| 41142826 | Roles of tumor-associated macrophages in triple-negative breast cancer progression. | Front Immunol | 2025 | https://conductscience.org/library/papers/41142826 | PubMed |
| 41093860 | Dendritic cell progenitors engineered to express extracellular-vesicle-internalizing receptors enhance cancer immunotherapy in mouse models. | Nat Commun | 2025 | https://conductscience.org/library/papers/41093860 | PubMed |
| 41075187 | 2240 nm NIR-IV Photodynamic Therapy Can Reverse Ineffective Anti-OX40 Cancer Immunotherapy to Become Effective. | ACS Nano | 2025 | https://conductscience.org/library/papers/41075187 | PubMed |
| 40805206 | Scaffold-Free Functional Deconvolution Identifies Clinically Relevant Metastatic Melanoma EV Biomarkers. | Cancers (Basel) | 2025 | https://conductscience.org/library/papers/40805206 | PubMed |
| 40646332 | Targeting CSF-1 signaling between tumor cells and macrophages at TMEM doorways inhibits breast cancer dissemination. | Oncogene | 2025 | https://conductscience.org/library/papers/40646332 | PubMed |
Genes32
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/29643229
GET https://conductscience.org/api/papers/v1/29643229/authors?page=2